Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dietary starches and other polysaccharides containing α-1,4-glycosidic linkages are complex carbohydrates that serve as the primary energy storage molecules in plants and a major caloric source for humans (PubChem, CID 24836924). These molecules, primarily amylose and amylopectin, consist of glucose units joined by α-1,4-glycosidic bonds, which are hydrolyzed by salivary and pancreatic alpha-amylase and intestinal alpha-glucosidase enzymes into absorbable monosaccharides (StatPearls, Alpha-Glucosidase Inhibitors). In clinical medicine, these polysaccharides are significant because their digestion rate directly influences postprandial glycemic levels, making them central to the management of Type 2 diabetes and obesity (NIH, PubMed PMID 11730160). While not a protein target themselves, they are the substrates for key therapeutic targets; drugs like acarbose and miglitol competitively inhibit the enzymes that break these linkages to slow glucose absorption (DrugBank, DB00284). This mechanism helps prevent rapid spikes in blood glucose following carbohydrate ingestion, thereby improving long-term glycemic control as measured by HbA1c.
Competitive inhibition of the enzymatic hydrolysis of α-1,4-glycosidic linkages by alpha-glucosidase and alpha-amylase enzymes (StatPearls).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-1,4-glucan (Dietary starch).